Attention-deficit hyperactivity disorder
Takeda’s Vyvanse faces generic competition after 16 years of ADHD dominance
Anika Sharma
Vyvanse, a blockbuster drug for attention-deficit/hyperactivity disorder (ADHD) and binge-eating disorder, has been the top choice for many patients and ...
Vyvanse Joins Adderall in Short Supply as Takeda’s Rival Faces Shortages
SG Tylor
Source – Fierce Pharma A competitor medication from Takeda is currently in low supply after a lengthy scarcity of the ...
